04/10/2025
📢 The Independence Through Enhancement of Medicare and Medicaid (ITEM) Coalition, coordinated by Powers Law, issued a statement in response to the Centers for Medicare & Medicaid Services’ (CMS) final rule on CY 2026 Medicare Advantage and Medicare Part D programs.
The Coalition and its members express disappointment in CMS’s decision not to expand coverage for anti-obesity medications and continue to advocate for broader access to these potentially life-changing treatments.
Read the full response, including insights from ITEM Co-Coordinators-Powers Managing Partner Peter Thomas and Director of Government Relations Michael Barnett-on the Powers website:
https://www.powerslaw.com/item-coalition-responds-to-cms-decision-on-anti-obesity-medication-coverage/
hashtag hashtag
On April 4,2025 the Centers for Medicare & Medicaid Services’ (CMS) issued the final rule for the CY 2026 Medicare Advantage and Medicare Part D programs. While the proposed expansion...
